The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Glimpse the Future

Glimpse the Future

November 1, 2007 • By Gretchen Henkel

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Dr. David Fox

You Might Also Like
  • ARHP in 2008
  • The Value of Mentoring in ARHP
  • Volunteers Essential to Future of the ACR, ARHP
Explore This Issue
November 2007
Also By This Author
  • Spring 2021’s Awards, Appointments & Announcements in Rheumatology
Dr. David Fox

ACR President

When he walks to the podium in Boston for his first official duties, incoming ACR President David A. Fox, MD, will be treading familiar turf. The three-year prelude to presidency – when candidates serve as secretary-treasurer, vice president, and then president-elect – is designed to educate future officers about the full spectrum of the ACR’s membership needs and issues. Dr. Fox found this lead-in period a valuable opportunity to work with and learn from senior staff members and fellow officers. “ACR structures its officers group to include a mixture of those in academics and private practice, so that we complement each other’s strengths and learn from each other,” he says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Fox is professor in the department of internal medicine, division chief of rheumatology, and director of the Rheumatic Disease Core Center at the University of Michigan Health System in Ann Arbor. He believes that attention to the needs of both academic and private practice members (the latter account for approximately 70% of the membership) has helped the ACR avoid the clinical-research division that occurs in other professional societies.

“The linkage between the practice side and the research side has so much to offer everybody,” he says. “The whole is greater than the sum of the parts. I think that’s what we see in our College, which is so valuable, is almost unique about rheumatology compared to other specialties in medicine, and is what we are very committed to preserving.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Challenges in the New Year

Dr. Fox inherits a full agenda as incoming president. Topping that list is maintaining excellence in the ACR’s ongoing core activities (annual scientific meetings, journals, and periodicals) while responding to members’ needs.

The latter increasingly involves participation in public policy. It’s a challenge, Dr. Fox admits, to stay abreast of the many public policy arenas in which the ACR is now active. Fortunately, the executive officers have help: ACR senior staff and the Washington, D.C.–based lobbying firm Patton Boggs stay tuned to federal legislation and help ACR leaders prioritize their lobbying efforts. In 2008, the ACR will likely be involved in lobbying Capitol Hill about the sustainable growth rate; the Arthritis Prevention, Control, and Cure Act of 2007; and the NIH research budget. Dr. Fox notes that the organization now understands that “we have to create awareness among legislators, and we have to repeatedly visit Capitol Hill.”

Keep Rheum In the Game

Research funding for arthritis has declined in the last four years. “In terms of real dollars, we are probably just about back to where we were about 10 years ago,” Dr. Fox says. Vying for a share of the NIH budget will likely get even more difficult. That’s why the ACR Research and Education Foundation’s (REF) “Within Our Reach” RA research fundraising campaign, under the leadership of James O’Dell, MD, has been timely – not only because of the money but because of the awareness it has raised. “What the public as a whole perhaps does not appreciate is that arthritis is a leading cause of disability in the United States,” says Dr. Fox. “Its impact, economically and health-wise, is way beyond the proportion of the research budget that goes to arthritis.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 | Single Page

Filed Under: Profiles Tagged With: ACR Research and Education Foundation (REF), Advocacy, Association of Rheumatology Professionals (ARP), Meet the Presidents, Pay-for-Performance, Quality, REF, Research FundingIssue: November 2007

You Might Also Like:
  • ARHP in 2008
  • The Value of Mentoring in ARHP
  • Volunteers Essential to Future of the ACR, ARHP
  • A Glimpse into the Life of New ACR President, Dr. Sharad Lakhanpal

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)